<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alajlouni D</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>NIH Roadmap for Medical Research</funding><funding>NIA NIH HHS</funding><funding>Australian Government Research Training Program</funding><funding>Australian Medical Research Futures Fund</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><funding>National Institute on Aging</funding><pagination>411-419</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8940659</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(3)</volume><pubmed_abstract>Muscle strength and physical performance are associated with fracture risk in men. However, it is not known whether these measurements enhance fracture prediction beyond Garvan and FRAX tools. A total of 5665 community-dwelling men, aged ≥65 years, from the Osteoporotic Fractures in Men (MrOS) Study, who had data on muscle strength (grip strength) and physical performance (gait speed and chair stand tests), were followed from 2000 to 2019 for any fracture, major osteoporotic fracture (MOF), initial hip, and any hip fracture. The contributions to different fracture outcomes were assessed using Cox's proportional hazard models. Tool-specific analysis approaches and outcome definitions were used. The added predictive values of muscle strength and physical performance beyond Garvan and FRAX we</pubmed_abstract><journal>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</journal><pubmed_title>Muscle Strength and Physical Performance Improve Fracture Risk Prediction Beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.</pubmed_title><pmcid>PMC8940659</pmcid><funding_grant_id>U01 AG042139</funding_grant_id><funding_grant_id>U01 AG042124</funding_grant_id><funding_grant_id>U01 AG042168</funding_grant_id><funding_grant_id>U01 AG042145</funding_grant_id><funding_grant_id>UL1 TR000128</funding_grant_id><funding_grant_id>UL1 TR002369</funding_grant_id><funding_grant_id>U01 AG042143</funding_grant_id><funding_grant_id>U01 AG027810</funding_grant_id><funding_grant_id>U01 AG042140</funding_grant_id><funding_grant_id>R01 AG066671</funding_grant_id><funding_grant_id>U01 AR066160</funding_grant_id><funding_grant_id>1137462</funding_grant_id><funding_grant_id>R56 AG061085</funding_grant_id><pubmed_authors>Center JR</pubmed_authors><pubmed_authors>Tran T</pubmed_authors><pubmed_authors>Orwoll ES</pubmed_authors><pubmed_authors>Bliuc D</pubmed_authors><pubmed_authors>Alajlouni D</pubmed_authors><pubmed_authors>Blank RD</pubmed_authors><pubmed_authors>Cawthon PM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Muscle Strength and Physical Performance Improve Fracture Risk Prediction Beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.</name><description>Muscle strength and physical performance are associated with fracture risk in men. However, it is not known whether these measurements enhance fracture prediction beyond Garvan and FRAX tools. A total of 5665 community-dwelling men, aged ≥65 years, from the Osteoporotic Fractures in Men (MrOS) Study, who had data on muscle strength (grip strength) and physical performance (gait speed and chair stand tests), were followed from 2000 to 2019 for any fracture, major osteoporotic fracture (MOF), initial hip, and any hip fracture. The contributions to different fracture outcomes were assessed using Cox's proportional hazard models. Tool-specific analysis approaches and outcome definitions were used. The added predictive values of muscle strength and physical performance beyond Garvan and FRAX we</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T21:43:52.239Z</modification><creation>2025-04-04T21:43:52.239Z</creation></dates><accession>S-EPMC8940659</accession><cross_references><pubmed>34842309</pubmed><doi>10.1002/jbmr.4483</doi></cross_references></HashMap>